The Section of Hematology at Rush University Medical Center in Chicago, Illinois, offers compassionate, multidisciplinary care for people with a variety of cancers that develop in bone marrow, blood and lymph nodes, including leukemia, lymphoma and multiple myeloma.

The section also treats patients with benign (noncancerous) blood disorders, such as anemia and aplastic anemia, as well as people with coagulation and thrombotic disorders, including hemophilia and deep vein thrombosis.

We offer a full range of standard and innovative treatments, including less toxic chemotherapy and a vaccine for non-Hodgkin’s lymphoma.

Our facilities include an on-site pharmacy, a dedicated room for diagnostic bone marrow procedures and a comfortable treatment area. Because we are committed to finding new treatments and helping to improve patient outcomes, our clinical staff is involved in a number of ongoing research projects.

The hematology team at Rush treats people with a variety of cancers that develop in the bone marrow, blood and lymph nodes. We also treat patients with benign blood disorders, including disorders characterized by an over- or underproduction of certain blood cells, such as aplastic anemia and the myeloproliferative disorders, and bleeding disorders such as hemophilia.

Hematologists at Rush provide care for people with the following conditions:

• Benign Blood Disorders
  Hematologists at Rush offer treatment for noncancerous blood disorders, including anemia, aplastic anemia, neutropenia, neutrophilia, thrombocytopenia and myeloproliferative disorders.
  

• Coagulation and Thrombotic Disorders
  Our specialists offer care for people with bleeding and thrombotic disorders, including hemophilia, von Willebrand’s disease, deep vein thrombosis, pulmonary embolism and the thrombocytopenias.
  

• Leukemias
  The Leukemia Program at Rush offers care for all types of leukemia, including pre-leukemic conditions such as myelodysplastic syndrome.
  

• Lymphomas
  The Comprehensive Lymphoma Center offers care for people with Hodgkin’s disease and non-Hodgkin’s lymphomas.
  

• Multiple Myeloma and Other Plasma Dyscrasias
  Treatment is available for this group of cancers characterized by the production of abnormal proteins, including multiple myeloma and Waldenstrom’s macroglobulinemia.

Stephanie Gregory, MD, is medical director of the Section of Hematology and Stem Cell Transplantation at Rush. Our team — including physicians, nurses, technicians and other health professionals — sees more than 4,500 patients each year. Every member of the team — from the physicians and nurses who provide clinical care to the office staff — is committed to treating our patients and their families with respect and compassion. To find hematologists at Rush, visit our online physician directory.